Literature DB >> 9702786

Calcium responses in fibroblasts from asymptomatic members of Alzheimer's disease families.

R Etcheberrigaray1, N Hirashima, L Nee, J Prince, S Govoni, M Racchi, R E Tanzi, D L Alkon.   

Abstract

We have previously identified alterations of K+ channel function, IP3-mediated calcium release, and Cp20 (a memory-associated GTP binding protein) in fibroblasts from Alzheimer's disease (AD) patients vs controls. Some of these alterations can be integrated into an index that distinguishes AD patients from controls with both high specificity and high sensitivity. We report here that alterations in IP3-mediated calcium responses are present in a large proportion of AD family members (i.e., individuals at high risk) before clinical symptoms of Alzheimer's disease are present. This was not the case if such members later "escaped" AD symptoms. This preclinical calcium signal correlate of later AD does not reflect, however, the presence of the PS1 familial AD gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9702786     DOI: 10.1006/nbdi.1998.0176

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  58 in total

1.  Calsenilin reverses presenilin-mediated enhancement of calcium signaling.

Authors:  M A Leissring; T R Yamasaki; W Wasco; J D Buxbaum; I Parker; F M LaFerla
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

2.  Lack of evidence for presenilins as endoplasmic reticulum Ca2+ leak channels.

Authors:  Dustin Shilling; Don-On Daniel Mak; David E Kang; J Kevin Foskett
Journal:  J Biol Chem       Date:  2012-02-06       Impact factor: 5.157

3.  Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons.

Authors:  Tristano Pancani; Jeremiah T Phelps; James L Searcy; Michael W Kilgore; Kuey-Chu Chen; Nada M Porter; Olivier Thibault
Journal:  J Neurochem       Date:  2009-05-11       Impact factor: 5.372

Review 4.  Regulatory Mechanisms of Endoplasmic Reticulum Resident IP3 Receptors.

Authors:  Syed Zahid Ali Shah; Deming Zhao; Sher Hayat Khan; Lifeng Yang
Journal:  J Mol Neurosci       Date:  2015-04-10       Impact factor: 3.444

Review 5.  Role of endolysosomes and inter-organellar signaling in brain disease.

Authors:  Zahra Afghah; Xuesong Chen; Jonathan D Geiger
Journal:  Neurobiol Dis       Date:  2019-11-09       Impact factor: 5.996

Review 6.  Interactions of Mitochondria/Metabolism and Calcium Regulation in Alzheimer's Disease: A Calcinist Point of View.

Authors:  Gary E Gibson; Ankita Thakkar
Journal:  Neurochem Res       Date:  2017-02-08       Impact factor: 3.996

Review 7.  Presenilin: RIP and beyond.

Authors:  Matthew R Hass; Chihiro Sato; Raphael Kopan; Guojun Zhao
Journal:  Semin Cell Dev Biol       Date:  2008-11-27       Impact factor: 7.727

Review 8.  The dysregulation of intracellular calcium in Alzheimer disease.

Authors:  Charlene Supnet; Ilya Bezprozvanny
Journal:  Cell Calcium       Date:  2010-01-18       Impact factor: 6.817

9.  Store depletion-induced h-channel plasticity rescues a channelopathy linked to Alzheimer's disease.

Authors:  Timothy F Musial; Elizabeth Molina-Campos; Linda A Bean; Natividad Ybarra; Ronen Borenstein; Matthew L Russo; Eric W Buss; Daniel Justus; Krystina M Neuman; Gelique D Ayala; Sheila A Mullen; Yuliya Voskobiynyk; Christopher T Tulisiak; Jasmine A Fels; Nicola J Corbett; Gabriel Carballo; Colette D Kennedy; Jelena Popovic; Josefina Ramos-Franco; Michael Fill; Melissa R Pergande; Jeffrey A Borgia; Grant T Corbett; Kalipada Pahan; Ye Han; Dane M Chetkovich; Robert J Vassar; Richard W Byrne; M Matthew Oh; Travis R Stoub; Stefan Remy; John F Disterhoft; Daniel A Nicholson
Journal:  Neurobiol Learn Mem       Date:  2018-06-12       Impact factor: 2.877

10.  Intracellular calcium deficits in Drosophila cholinergic neurons expressing wild type or FAD-mutant presenilin.

Authors:  Kinga Michno; David Knight; Jorge M Campusano; Jorge M Campussano; Diana van de Hoef; Gabrielle L Boulianne
Journal:  PLoS One       Date:  2009-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.